Mar 28, 2022 – Congratulations to Élisabeth Canitrot on the successful defense of her PhD thesis in epidemiology at Université Laval. The title of her research was the “Use of activated charcoal in a poisoned pediatric population”. Élisabeth was examined on March 21, 2022 by Drs. Maude St-Onge, Lynne Moore, Alexis F. Turgeon, Michaël Chassé, Caroline… Read more »
Mar 3, 2022 – The Dean of the Faculty of Graduate and Postdoctoral Studies (FGPS), Mrs. Josée Bastien, congratulates Noémie on the final submission of her master’s thesis (Master of Science in Epidemiology program with thesis, at Université Laval). We wish Noémie all the success expected for her projects and research program.
Nov 22, 2021 – In a large international randomized clinical trial of more than 2,000 patients with COVID-19 and hospitalized in intensive care units worldwide, treatment with convalescent plasma showed a low likelihood of improving the number of days alive without organ support therapy. Read the publication in JAMA: https://jamanetwork.com/journals/jama/fullarticle/2784914 The publication in JAMA confirms… Read more »
Nov 22, 2021 – The results of a systematic review exploring the association of intensive (ie, lower than usual) blood pressure (BP) reduction vs standard BP management with the incidence of cognitive decline and dementia in adults with hypertension have been published in JAMA: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2786418 In summary: Current available evidence does not justify the use… Read more »
Oct 5, 2021 – The results of the randomized clinical trial PROSPECT (Probiotics to prevent Severe Pneumonia and Endotracheal Colonization Trial) have been published in JAMA: https://jamanetwork.com/journals/jama/article-abstract/2784358 In summary: Among critically ill patients requiring mechanical ventilation, administration of the probiotic L rhamnosus GG compared to placebo, resulted in no significant difference in the development of… Read more »
Sep 22, 2021 – Several milestones have been achieved over the last months: 50% enrollment has been reached; Two records were broken: in June, sites collectively enrolled 24 patients! Our previous monthly record was 22 patients; the Sunnybrook team randomized 6 patients in June. A first HEMOTION patient was enrolled in Brazil. We are grateful… Read more »
Sep 17, 2021 – The results of the randomized controlled trial CONCOR-1 (Convalescent Plasma for COVID-19 Respiratory Illness) have been published in Nature Medicine: https://www.nature.com/articles/s41591-021-01488-2 In summary: Convalescent plasma did not reduce the risk of intubation or death in hospitalized patients with COVID-19. However, the study also revealed that the antibody profile in the blood… Read more »
Jun 10, 2021 – Congratulations to Élisabeth Canitrot, Godwill Abiala, Chartelin Jean Isaac and Thierry Rouleau Bonenfant, each of them recipients of one “Prize for the oral presentation” of their respective projects and, Cécile Duval and Alexandre Bergeron, winners of a “Prize for aid to dissemination” for their respective poster presentations. The presentations were given as… Read more »
Jun 2, 2021 – Jihad Abou Jamous, a student in the Master of Science in Epidemiology program with thesis at Université Laval, made the final submission of his thesis on April 7th. For his work Jihad received the congratulations of the Dean of the Faculty of Graduate and Postdoctoral Studies.
May 15, 2021 – On this page, you will find a list of our recent research publications relevant to our work in the COVID-19 field. These highlighted articles are from our team and also involve collaborations. 1: Tremblay K, Rousseau S, Zawati MH, Auld D, Chassé M, Coderre D, Falcone EL, Gauthier N, Grandvaux N, Gros-Louis… Read more »
